Galectin-3 predicts response and outcomes after cardiac resynchronization therapy

Galectin-3 predicts response and outcomes after cardiac resynchronization therapy

Abstract Background Cardiac resynchronization therapy (CRT) reduces symptoms, morbidity and mortality in chronic heart failure patients with wide QRS complexes. However, approximately one third of CRT patients are non-responders. Myocardial fibrosis is known to be associated with absence of response...

Full description

Bibliographic Details
Main Authors: Clémentine Andre, Eric Piver, Romain Perault, Arnaud Bisson, Julien Pucheux, Emmanuelle Vermes, Bertrand Pierre, Laurent Fauchier, Dominique Babuty, Nicolas Clementy
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Journal of Translational Medicine
Subjects:
Galectin-3
Heart failure
Cardiac resynchronization therapy
Online Access:http://link.springer.com/article/10.1186/s12967-018-1675-4

Internet

http://link.springer.com/article/10.1186/s12967-018-1675-4

Similar Items